American Diabetes Association Scientific Sessions
Q&A: AI in diabetes care poses many challenges, benefits to patients and clinicians
AI in diabetes care is becoming more popular with various potential benefits for patients and clinicians as well as important challenges to keep in mind, according to a conversation between two diabetes experts.
VIDEO: Important to not ‘exacerbate’ existing disparities with AI
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about the importance of not worsening disparities with the implementation of AI in diabetes care.
VIDEO: The role of clinicians, stakeholders for AI in diabetes
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about important considerations for using AI in clinical practice.
VIDEO: AI poses potential benefits, challenges in diabetes care
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about the benefits and challenges of using AI in diabetes care.
Sustained reduction in HbA1c for adults with type 2 diabetes after starting CGM
ORLANDO — Adults with type 2 diabetes experienced a reduction in HbA1c within 3 months of starting continuous glucose monitoring, regardless of insulin therapy, a presenter reported at the American Diabetes Association Scientific Sessions.
Bisphenol A tied to decreased insulin sensitivity for healthy adults
ORLANDO — Exposure to bisphenol A may lower insulin sensitivity for healthy adults and may lead to higher risk for type 2 diabetes, according to a speaker at the American Diabetes Association Scientific Sessions.
Q&A: Award winner changes career focus after diabetes diagnosis
Shortly after graduating pharmacy school, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, was diagnosed with type 1 diabetes. Learning how to manage the disease while also going through pharmacy training was overwhelming, he said.
VIDEO: Equal access necessary to realize CGM benefits in pregnancy
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about benefits of use of continuous glucose monitoring during pregnancy.
Q&A: CGM ‘revolutionary’ for pregnant women with diabetes
Continuous glucose monitors have the potential to alleviate burdens, improve neonatal outcomes and predict disease progression for pregnant women with type 1, type 2 or gestational diabetes, according to two diabetes experts.
VIDEO: CGM is potential tool during pregnancy, postpartum
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about benefits of use of continuous glucose monitoring during and after pregnancy.